http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-075161-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4d668d7bfa57aac7f2d49267c07cc4c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 |
| filingDate | 2010-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca9a71094ceaf1786e7e9f9864e9ef23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92593b53fee2dbb91dac4ef9e14aaf22 |
| publicationDate | 2011-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-075161-A1 |
| titleOfInvention | ASTHMA TREATMENT WITH DELAYED RELEASE GLUCOCORTICOIDS |
| abstract | Claim 1: A method for the treatment of a patient suffering from asthma, comprising administering to said patient an effective amount of a glucocorticoid contained in a delayed release form, wherein said treatment is administered for at least 2 weeks. Claim 6: A method for the treatment of a patient suffering from uncontrolled asthma, particularly uncontrolled asthma with nighttime awakenings, comprising administering to said patient an effective amount of glucocorticoid contained in a delayed-release dose form, wherein Such treatment is administered for at least 2 weeks. Claim 18: The method of claim 1, 6 or 7, further comprising administering to said patient an effective amount of inhaled glucocorticoids, short and long-acting adrenergic beta2 receptor agonists, leukotriene antagonists, theophylline or combinations thereof. same. Claim 30: The method of claim 1, 6 or 7, wherein the delayed release dose form is a tablet or a capsule. Claim 31: The method of claim 30, wherein the delayed release dose form does not have an enteric coating and has a drug release behavior that is independent of pH. Claim 33: The method of claim 1, 6 or 7, wherein the glucocorticoid is cortisone, hydrocortisone, prednisone, prednisolone, methylprednisolone, budesonide, dexamethasone, fludrocortisone, fluocortolone, cloprednol, deflazacort, or corresponding pharmaceutically acceptable salts. / or esters thereof. |
| priorityDate | 2009-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.